YS BIOPHARMA CO LTD - ORDINARY SHARES (LSB)

CUSIP: G9845F109

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / ORDINARY SHARES
Total 13F shares
5,118,717
Share change
-203,484
Total reported value
$3,335,030
Price per share
$0.65
Number of holders
11
Value change
-$237,864
Number of buys
4
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G9845F109?
CUSIP G9845F109 identifies LSB - YS BIOPHARMA CO LTD - ORDINARY SHARES in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of YS BIOPHARMA CO LTD - ORDINARY SHARES (LSB) as of Q2 2024

As of 30 Jun 2024, YS BIOPHARMA CO LTD - ORDINARY SHARES (LSB) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,118,717 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, HHLR ADVISORS, LTD., FIL Ltd, SUPERSTRING CAPITAL MANAGEMENT LP, BANK OF MONTREAL /CAN/, BARCLAYS PLC, Ovata Capital Management Ltd, CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.